{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:41:38Z","timestamp":1789429298524,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1111\/j.1574-6968.2007.00850.x","type":"journal-article","created":{"date-parts":[[2007,7,20]],"date-time":"2007-07-20T12:48:44Z","timestamp":1184935724000},"page":"279-286","source":"Crossref","is-referenced-by-count":37,"title":["Gomesin, a peptide produced by the spider<i>Acanthoscurria gomesiana<\/i>, is a potent anticryptococcal agent that acts in synergism with fluconazole"],"prefix":"10.1093","volume":"274","author":[{"given":"Fabiane M.","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirlei","family":"Daffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa A.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Nimrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio L.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB1","unstructured":"Baddley JW & Pappas PG (2005) Antifungal combination therapy: clinical potential. Drugs 65: 1461\u00e2\u0080\u00931480."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB2","doi-asserted-by":"crossref","unstructured":"Barbosa FM , Fonseca FL , Holandino C , Alviano CS , Nimrichter L & Rodrigues ML (2006) Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage. Microbes Infect 8: 493\u00e2\u0080\u0093502.","DOI":"10.1016\/j.micinf.2005.07.027"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB3","unstructured":"Bicanic T & Harrison TS (2004) Cryptococcal meningitis. Br Med Bull 72: 99\u00e2\u0080\u0093118."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB4","doi-asserted-by":"crossref","unstructured":"Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238\u00e2\u0080\u0093250.","DOI":"10.1038\/nrmicro1098"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB5","unstructured":"Brown KL & Hancock RE (2006) Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18: 24\u00e2\u0080\u009330."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB6","doi-asserted-by":"crossref","unstructured":"Casadevall A , Mukherjee J & Scharff MD (1992) Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods 154: 27\u00e2\u0080\u009335.","DOI":"10.1016\/0022-1759(92)90209-C"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB8","unstructured":"Dan JM & Levitz SM (2006) Prospects for development of vaccines against fungal diseases. Drug Resist Updat 9: 105\u00e2\u0080\u0093110."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB9","unstructured":"Del Valle L & Pi\u00c3\u00b1a-Oviedo S (2006) HIV disorders of the brain: pathology and pathogenesis. Front Biosci 11: 718\u00e2\u0080\u0093732."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB10","doi-asserted-by":"crossref","unstructured":"Fazio MA , Oliveira VX Jr , Bulet P , Miranda MT , Daffre S & Miranda A (2006a) Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Biopolymers 84: 205\u00e2\u0080\u0093218.","DOI":"10.1002\/bip.20396"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB11","doi-asserted-by":"crossref","unstructured":"Fazio MA , Jouvensal L , Vovelle F , Bulet P , Miranda MT , Daffre S & Miranda A (2006b) Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices. Biopolymers 88: 386\u00e2\u0080\u0093400.","DOI":"10.1002\/bip.20660"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB12","doi-asserted-by":"crossref","unstructured":"Feldmesser M , Tucker S & Casadevall A (2001) Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 9: 273\u00e2\u0080\u0093278.","DOI":"10.1016\/S0966-842X(01)02035-2"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB13","doi-asserted-by":"crossref","unstructured":"Garc\u00c3\u00ada-Rivera J , Chang YC , Kwon-Chung KJ & Casadevall A (2004) Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell 3: 385\u00e2\u0080\u0093392.","DOI":"10.1128\/EC.3.2.385-392.2004"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB14","doi-asserted-by":"crossref","unstructured":"Kichler A , Mason AJ & Bechinger B (2006) Cationic amphipathic histidine-rich peptides for gene delivery. Biochim Biophys Acta 1758: 301\u00e2\u0080\u0093307.","DOI":"10.1016\/j.bbamem.2006.02.005"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB15","unstructured":"Kueltzo LA & Middaugh CR (2003) Nonclassical transport proteins and peptides: an alternative to classical macromolecule delivery systems. J Pharm Sci 92: 1754\u00e2\u0080\u00931772."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB16","doi-asserted-by":"crossref","unstructured":"Lee SC , Dickson DW , Brosnan CF & Casadevall A (1994) Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 180: 365\u00e2\u0080\u0093369.","DOI":"10.1084\/jem.180.1.365"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB17","doi-asserted-by":"crossref","unstructured":"Lorenzini DM , Fukuzawa AH , da Silva PI Jr , Machado-Santelli G , Bijovsky AT & Daffre S (2003) Molecular cloning, expression analysis and cellular localization of gomesin, an anti-microbial peptide from hemocytes of the spider Acanthoscurria gomesiana. Insect Biochem Mol Biol 33: 1011\u00e2\u0080\u00931016.","DOI":"10.1016\/S0965-1748(03)00115-2"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB18","doi-asserted-by":"crossref","unstructured":"Mandard N , Bulet P , Caille A , Daffre S & Vovelle F (2002) The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. Eur J Biochem 269: 1190\u00e2\u0080\u00931198.","DOI":"10.1046\/j.0014-2956.2002.02760.x"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB19","doi-asserted-by":"crossref","unstructured":"Mangoni ML , Papo N , Barra D , Simmaco M , Bozzi A , Di Giulio A & Rinaldi AC (2004) Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem J 380: 859\u00e2\u0080\u0093865.","DOI":"10.1042\/bj20031975"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB20","doi-asserted-by":"crossref","unstructured":"Moreira CK , Rodrigues FG , Ghosh A , Varotti FD , Miranda A , Daffre S , Jacobs-Lorena M & Moreira LA (2007) Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Exp Parasitol, http:\/\/dx.doi.org\/10.1016\/j.exppara.2007.01.022","DOI":"10.1016\/j.exppara.2007.01.022"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB21","doi-asserted-by":"crossref","unstructured":"Perfect JR & Casadevall A (2002) Cryptococcosis. Infect Dis Clin North Am 16: 837\u00e2\u0080\u0093874 v-vi.","DOI":"10.1016\/S0891-5520(02)00036-3"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB23","doi-asserted-by":"crossref","unstructured":"Rodrigues ML , Rozental S , Couceiro JN , Angluster J , Alviano CS & Travassos LR (1997) Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis. Infect Immun 65: 4937\u00e2\u0080\u00934942.","DOI":"10.1128\/IAI.65.12.4937-4942.1997"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB22","doi-asserted-by":"crossref","unstructured":"Rodrigues ML , Alviano CS & Travassos LR (1999) Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms. Microbes Infect 1: 293\u00e2\u0080\u0093301.","DOI":"10.1016\/S1286-4579(99)80025-2"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB24","doi-asserted-by":"crossref","unstructured":"Rodrigues ML , Travassos LR , Miranda KR et al. (2000) Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect Immun 68: 7049\u00e2\u0080\u00937060.","DOI":"10.1128\/IAI.68.12.7049-7060.2000"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB25","doi-asserted-by":"crossref","unstructured":"Rosas AL , Nosanchuk JD & Casadevall A (2001) Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect Immun 69: 3410\u00e2\u0080\u00933412.","DOI":"10.1128\/IAI.69.5.3410-3412.2001"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB26","unstructured":"Silva PI Jr , Daffre S & Bulet P (2000) Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J Biol Chem 275: 33464\u00e2\u0080\u009333470."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB27","unstructured":"Trehin R & Merkle HP (2004) Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm 58: 209\u00e2\u0080\u0093223."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB28","unstructured":"Tucker SC & Casadevall A (2002) Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci U S A 99: 3165\u00e2\u0080\u00933170."},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB29","doi-asserted-by":"crossref","unstructured":"Vecchiarelli A (2000) Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 38: 407\u00e2\u0080\u0093417.","DOI":"10.1080\/714030973"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB30","doi-asserted-by":"crossref","unstructured":"Yount NY , Bayer AS , Xiong YQ & Yeaman MR (2006) Advances in antimicrobial peptide immunobiology. Biopolymers 84: 435\u00e2\u0080\u0093458.","DOI":"10.1002\/bip.20543"},{"key":"10.1111\/j.1574-6968.2007.00850.x-BIB31","doi-asserted-by":"crossref","unstructured":"Zaragoza O , Telzak A , Bryan RA , Dadachova E & Casadevall A (2006) The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol Microbiol 59: 67\u00e2\u0080\u009383.","DOI":"10.1111\/j.1365-2958.2005.04928.x"}],"container-title":["FEMS Microbiology Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsle\/article-pdf\/274\/2\/279\/19119941\/274-2-279.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T07:49:30Z","timestamp":1587800970000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsle\/article-lookup\/doi\/10.1111\/j.1574-6968.2007.00850.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-6968.2007.00850.x","relation":{},"ISSN":["0378-1097","1574-6968"],"issn-type":[{"value":"0378-1097","type":"print"},{"value":"1574-6968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}